2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Abstract Number: 2331

Obesity Might Positively Affect TNF Mediated Bone Metabolism in RA Patients
Abstract Number: 969

Obstetric Outcomes in Women with Psoriatic Arthritis: Results from Nationwide Inpatient Sample Database 2003-2011
Abstract Number: 2434

Obstetric Outcomes in Women with Takayasu Arteritis: Results from Nationwide Inpatient Sample Database 2003-2011
Abstract Number: 424

Occult Extractable Synovial Fluid in Inflammatory and Non-Inflammatory Arthritis of the Knee
Abstract Number: 201

Occupational Exposure to Coal and Silica Dust Is Associated with Elevated Risk of Rheumatoid Arthritis in Coal Mining Areas of US
Abstract Number: 1767

Occurrence and Etiology of Gastrointestinal Perforation in Patients with Vasculitis
Abstract Number: 2267

Ocular and Systemic Features in 262 Patients with Systemic Sarcoidosis and Its Correlation with Iwos Criteria
Abstract Number: 1491

Oestrogen Levels and the Outcome of Leflunomide Treatment in Rheumatoid Arthritis
Abstract Number: 461

Ofatumumab Use in Childhood-Onset Systemic Lupus Erythematosus: A Single-Center Experience
Abstract Number: 2062

Omentin-1: Potential Biomarker of Cardiovascular Risk in Axial Spondyloarthritis? a Serological and Genetic Study
Abstract Number: 2824

On Tapering Therapy for RA Patients in Clinical Remission; Flare on Csdmards Predicted By Clinical Features and Musculoskeletal Ultrasound, Whereas T-Cell Abnormalities Predictive for b-DMARD Tapering
Abstract Number: 427

One Year Efficacy and Safety of One or Three Injections of Hylan G-F 20 for Knee Osteoarthritis: A Systematic Literature Review and Meta-Analysis
Abstract Number: 1099

Ongoing DNA Damage, Chromatin Deregulation and Defective DNA Damage Response in Systemic Autoimmune Rheumatic Diseases
Abstract Number: 2193

Online Direct-to-Patient Recruitment for Systemic Lupus Erythematosus Results in Rapid Enrollment
Abstract Number: 375

Only a Minor Proportion of Individuals with Anti-Aminoacyl-tRNA Synthetase Autoimmunity Presents with the Clinical Picture of “Antisynthetase-Syndrome”
Abstract Number: 1302

Opioid Analgesic Use in Acute Gout Patients Discharged from the Hospital
Abstract Number: 2998

Opioid Use Among SLE Patients and Controls in the Population-Based Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
Abstract Number: 2737

Opportunistic Infections in Medium and Small-Sized Vessel Vasculitis: Based on a Retrospectivestudy on 108 Patients
Abstract Number: 2315

Opportunistic Screening for Osteoporosis Using Thoraco-Abdomino-Pelvic Computed Tomography Assessing the Vertebral Density in Rheumatoid Arthritis Patients
Abstract Number: 1049

Optical Biomarkers for the Early Diagnosis of Osteoarthritis
Abstract Number: 1444

Optimization of Ultrasonographic Examination for the Diagnosis of Erosive Rheumatoid Arthritis Versus Erosive Osteoarthritis with Radiography Considered As Gold Standard
Abstract Number: 1804

Optimization Protocol for Adalimumab Treatment in Refractory Uveitis Due to Behçet’s Disease
Abstract Number: 2705

Optimized Protocol for Extracorporeal Shock Wave Therapy on Digital Ulcers in Systemic Sclerosis
Abstract Number: 342

Optimizing the Dataset to Collect from Patients to Accurately Predict Their Status Prior to the Clinic Visit
Abstract Number: 2017

Oral Microbiota in New-Onset Juvenile Idiopathic Arthritis
Abstract Number: 1031

Orally Administered Cherry Juice Inhibits Localized Nfκb Activity and Histopathological Infiltrates in a Murine Model of Gout
Abstract Number: 1301

Organic Anion Transport Inhibitors Suppress Chondrocyte Pyrophosphate Production
Abstract Number: 46

Organic Dust Inhalants Shift Immune Responses and Extracellular Matrix Balance between Synovium and Lung in the Collagen-Induced Arthritis Mouse Model
Abstract Number: 1239

Organisms Associated with Prosthetic Joint Septic Arthritis over the Past Two Decades: Data from a Single Tertiary Medical Center Located in the Northeastern United States
Abstract Number: 1904

Orphan Nuclear Receptor Rorα Is a Key Regulator of Tgfβ- and WNT-Signaling in Fibrotic Diseases
Abstract Number: 1994

Osteoarthritis Severity Is Reduced By Intra-Articular Administration of Hydrogen Sulfide
Abstract Number: 1824

Osteoclast Derived-Autotaxin, a Distinguishing Factor for Inflammatory Bone Loss
Abstract Number: 2335

Osteoporotic Fracture Trends in a Population of US Managed Care Enrollees: 2007-2017
Abstract Number: 260

Outcome Expectations and Fibromyalgia: Perceived Benefits of Exercise Are Associated with Self-Efficacy and Physical Performance
Abstract Number: 743

Outcome of Stroke in Patients with Systemic Lupus Erythematosus: A Nested Case-Control Study
Abstract Number: 239

Outcomes of Hospitalizations and the Temporal Trends in Mortality from Acute Myocardial Infarction in Patients with RA and FM during 2005 to 2015
Abstract Number: 2440

Outcomes of Pregnancy Complicated By ANCA-Associated Vasculitis: A Retrospective Review
Abstract Number: 277

Outcomes of Telemedicine for Rheumatoid Arthritis in the Alaska Native Population
Abstract Number: 2326

Outcomes One Year after Hip Fracture Repair in the Elderly: Does Social Isolation Matter?
Abstract Number: 2172

Overuse of Glucocorticoids in Rheumatoid Arthritis: A National Survey of Primary Care Physicians

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].